secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0000950170-23-032992
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics extends office lease through April 2027, modifies rent and abatements
--------------------------------------------------------------------------------

- Lease term extended from April 30, 2024 to April 30, 2027.
- Base rent from May 1, 2024 set at $95.67/sq ft/year (~22,343 sq ft), with 3% annual increases.
- Rent abatements for May 2024 and May 2025 (one month each).
- Tenant's early termination right (Sixth Amendment Section 4) revoked.
- Landlord responsible for building system repairs for 30 days after Extension Commencement Date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000095017023032992/0000950170-23-032992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000095017023032992/lyra-20230712.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-032992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer